review Open Access
A review article on sublingual tablet of lansoprazole
Journal of Pharmacognosy and Phytochemistry · 2019 · Vol. 8(6) · pp. 714–721
Abstract
Solid dispersion technology using mixed solvency Introduced in oral product facilitate the tablet of active drug. Lansoprazole is PPI (Proton Pump Inhibitors) used to treat of anti-ulcer. Sublingual based oral drug delivery system to avoid first pass metabolism, less side effects.
Analytical Methods in PharmaceuticalsDrug Solubulity and Delivery SystemsHelicobacter pylori-related gastroenterology studiesLansoprazoleFirst pass effectMedicinePharmacologyDrug
Citations
0
FWCI
0.00
field-weighted impact
References
0
Percentile
33%
vs. same field & year
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.